Bellicum Pharmaceuticals Inc. closed its underwritten public offering of 5,750,000 common shares priced at $12 per share.

The amount includes 750,000 shares that were issued as part of an overallotment option fully exercised by underwriters.

All in all, the company raised $69 million with Citigroup and Jefferies acting as the lead book-running managers for the offering. Guggenheim Securities, Ladenburg Thalmann, Raymond James and SunTrust Robinson Humphrey acted as co-managers.